Cite
Herrington WG, Goldsack JC, Landray MJ. Increasing the use of mobile technology-derived endpoints in clinical trials. Clin Trials. 2018;15(3):313-315doi: 10.1177/1740774518755393.
Herrington, W. G., Goldsack, J. C., & Landray, M. J. (2018). Increasing the use of mobile technology-derived endpoints in clinical trials. Clinical trials (London, England), 15(3), 313-315. https://doi.org/10.1177/1740774518755393
Herrington, William G, et al. "Increasing the use of mobile technology-derived endpoints in clinical trials." Clinical trials (London, England) vol. 15,3 (2018): 313-315. doi: https://doi.org/10.1177/1740774518755393
Herrington WG, Goldsack JC, Landray MJ. Increasing the use of mobile technology-derived endpoints in clinical trials. Clin Trials. 2018 Jun;15(3):313-315. doi: 10.1177/1740774518755393. Epub 2018 Feb 05. PMID: 29400066; PMCID: PMC5992831.
Copy
Download .nbib